| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,510 | 5,520 | 09:58 | |
| 5,505 | 5,520 | 09:58 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 5,535 | 724 | |||
| 5,530 | 1.362 | |||
| 5,525 | 3.272 | |||
| 5,520 | 1.620 | |||
| 5,515 | 815 | |||
| 5,510 | 2.623 | |||
| 5,505 | 1.659 | |||
| 5,500 | 6.843 | |||
| 5,495 | 2.729 | |||
| 5,490 | 432 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/evt.htm [/URL] | ||||
| 601 | 5,480 | |||
| 2.675 | 5,475 | |||
| 508 | 5,470 | |||
| 499 | 5,465 | |||
| 474 | 5,460 | |||
| 1.224 | 5,455 | |||
| 474 | 5,450 | |||
| 3.721 | 5,445 | |||
| 6.539 | 5,440 | |||
| 474 | 5,435 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 17.189 | 1,284 | 22.079 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 09:42:25 | 5,490 | 316 |
| 09:42:25 | 5,505 | 148 |
| 09:42:11 | 5,510 | 700 |
| 09:39:52 | 5,520 | 338 |
| 09:38:52 | 5,530 | 164 |
| 09:38:16 | 5,530 | 163 |
| 09:38:16 | 5,540 | 100 |
| 09:38:10 | 5,528 | 164 |
| 09:37:05 | 5,515 | 1.223 |
| 09:37:05 | 5,510 | 25 |
| 09:37:05 | 5,510 | 335 |
| 09:37:05 | 5,510 | 800 |
| 09:37:04 | 5,495 | 338 |
| 09:37:04 | 5,480 | 319 |
| 09:37:04 | 5,485 | 79 |
| 09:36:34 | 5,495 | 78 |
| 09:36:22 | 5,505 | 715 |
| 09:34:22 | 5,485 | 7 |
| 09:34:21 | 5,495 | 504 |
| 09:34:01 | 5,485 | 86 |
| Tagesumsatz Xetra | +0,100 +1,86 % | 177.727 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:02 | EVOTEC SE in geordneter Marktstruktur | 30 | Maximilian Berger | ||
| EVOTEC Aktie jetzt für 0€ handeln | |||||
| 08:30 | BRANDMELDUNG bei Evotec: 15,8% Plus und das könnte erst der Anfang sein - Was das für Ihr Depot bedeutet | Hebelschein-Spekulant | |||
| 08:27 | Evotec ernennt Ingrid Müller zur Chief Operating Officer ab 1. Mai | 266 | Dow Jones News | DJ Evotec ernennt Ingrid Müller zur Chief Operating Officer ab 1. Mai
DOW JONES--Evotec hat zum 1. Mai Ingrid Müller zur Chief Operating Officer (COO) und Mitglied des Vorstands ernannt. Müller... ► Artikel lesen | |
| 08:18 | Evotec appoints Ingrid Müller as chief operating officer | 17 | Investing.com | ||
| 08:10 | Evotec SE: Dr. Ingrid Müller wird neue COO ab 1. Mai 2026 | 22 | Investing.com Deutsch |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 07:03 | Adhoc: MindMaze Therapeutics Holding SA: MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update | EQS Group (EN) | MindMaze Therapeutics Holding SA / Key word(s): Annual Results
MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update
15-Apr-2026 / 07:00 CET/CEST
Release of an ad hoc... ► Artikel lesen | |
| 07:03 | BioVersys AG: BioVersys to present data on clinical and preclinical pipeline programs at ESCMID Global 2026 | EQS Group (EN) | BioVersys AG
/ Key word(s): Conference
BioVersys to present data on clinical and preclinical pipeline programs at ESCMID Global 2026 15.04.2026 / 07:00 CET/CEST
Basel, Switzerland.... ► Artikel lesen | |
| 00:48 | Telix Pharmaceuticals Limited: Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds | PR Newswire | MELBOURNE, Australia and Indianapolis, April 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ("Telix") is pleased to announce that it has successfully priced... ► Artikel lesen | |
| Di | Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting | GlobeNewswire (Europe) | ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR
Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage... ► Artikel lesen | |
| Di | QIAGEN N.V.: QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel | Business Wire | QIAstat-Dx BCID GPF Plus AMR Panel detects gram-positive bacteria, fungi and key antimicrobial resistance markers from positive blood cultures and colonies CE-IVDR-certified panel identifies... ► Artikel lesen |